4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001104659-15-081129
Chief Executive Officer acquired 7,229 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TABUTEAU HERRIOT Chief Executive Officer | 2015-11-24 | Conversion | +7,229 | $5.94 | $42,940 | 7,229 | D |
| Derivatives | |||||||
| TABUTEAU HERRIOT Chief Executive Officer | 2015-11-24 | Grant or award · 8% Convertible Note | +7,229 | 0 | D | ||
Loading xslF345X03/a4.xml…